Adaptable PTH Compounds for Niche Environments

Publication ID: 24-11857603_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptable PTH Compounds for Niche Environments,” Published Technical Disclosure No. 24-11857603_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857603_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,603.

Summary of the Inventive Concept

The present inventive concept relates to specialized PTH compounds and systems adapted for treating hypoparathyroidism in unique operational environments, including extreme weather conditions, disaster relief, high-security facilities, remote areas, and areas with limited access to medical care.

Background and Problem Solved

The original patent disclosed PTH compounds with low peak-to-trough ratios for treating hypoparathyroidism. However, these compounds may not be suitable for use in specialized environments where refrigeration, power supply, and medical infrastructure may be limited or unreliable. The present inventive concept addresses these limitations by providing adaptable PTH compounds and systems that can operate effectively in these niche environments.

Detailed Description of the Inventive Concept

The inventive concept encompasses various embodiments, including portable, temperature-controlled containers for storing PTH compounds, subcutaneous administration devices, backup power sources for refrigeration, tamper-evident containers, satellite-enabled communication devices, and portable, solar-powered refrigeration units. These components work together to ensure the effective delivery of PTH compounds with low peak-to-trough ratios in challenging environments.

Novelty and Inventive Step

The new claims introduce novel combinations of PTH compounds and specialized systems that enable the treatment of hypoparathyroidism in unique operational environments. The inventive step lies in the adaptation of the original PTH compounds to these niche environments, which requires careful consideration of factors such as temperature control, power supply, and medical infrastructure.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different refrigeration methods, such as dry ice or evaporative cooling, or the integration of additional features, such as GPS tracking or remote monitoring, to enhance the functionality of the systems. Variations of the inventive concept could also be developed for treating other medical conditions that require specialized environments.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the pharmaceutical and medical device industries, particularly in the areas of disaster relief, remote healthcare, and high-security medical facilities. The market for these specialized PTH compounds and systems is expected to grow as the need for adaptable medical solutions in niche environments increases.

CPC Classifications

SectionClassGroup
A A61 A61K38/29
A A61 A61K9/00
A A61 A61K47/34
A A61 A61K47/60

Field of Art

Pharmaceutical biotechnology, specifically peptide-based therapeutic compositions for endocrine disorders, with expertise in pharmacokinetic formulation, drug delivery systems, and medical device design

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in pharmaceutical sciences or biomedical engineering, experienced in developing injectable peptide therapeutics, understanding pharmacokinetic principles, and designing medical delivery systems

Obviousness Rationale

A person of ordinary skill would recognize that the specialized PTH compound delivery systems represent predictable engineering adaptations of the source patent's core pharmaceutical technology. The fundamental innovation of low peak-to-trough ratio PTH compounds provides a clear technological foundation for exploring contextual delivery variations. The PTD's environmental and logistical modifications represent standard problem-solving approaches in pharmaceutical engineering, leveraging known techniques for drug preservation and administration.

Obvious Combinations & Variations

Source Patent Element
Subcutaneous PTH compound administration with peak-to-trough ratio less than 4
PTD Variation
Temperature-controlled portable containers and specialized refrigeration systems for PTH compound storage
Obviousness Reasoning
Predictable solution for maintaining pharmaceutical stability, using known temperature control techniques in medical device engineering
Source Patent Element
Hypoparathyroidism treatment method with specific administration interval
PTD Variation
Satellite-enabled communication devices and remote monitoring systems for medication management
Obviousness Reasoning
Routine technological integration of telecommunications with medical delivery systems, representing a standard design optimization
Source Patent Element
Subcutaneous injection of PTH compound
PTD Variation
Automated, user-friendly injection devices for challenging environmental conditions
Obviousness Reasoning
Predictable engineering adaptation addressing known challenges in medical device usability and reliability
Source Patent Element
Pharmaceutical composition with specific pharmacokinetic profile
PTD Variation
Tamper-evident containers and secure storage solutions for high-security environments
Obviousness Reasoning
Conventional security enhancement technique applying standard pharmaceutical packaging principles
Source Patent Element
PTH compound with consistent pharmacological performance
PTD Variation
Solar-powered refrigeration units for maintaining medication integrity in remote locations
Obviousness Reasoning
Logical extension of existing medical preservation technologies using renewable energy solutions
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in this publication would have been obvious to a person of ordinary skill in the art at the time of invention, based on the teachings of US Patent 11857603. The systematic adaptations of PTH compound delivery represent predictable technological extensions that do not rise to the level of non-obvious innovation, thereby establishing this disclosure as anticipatory prior art against potential future patent claims in this technological domain.

Original Patent Information

Patent NumberUS 11,857,603
TitlePTH compounds with low peak-to-trough ratios
Assignee(s)ASCENDIS PHARMA BONE DISEASES A/S